The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)

Seoul National University

Status: Completed

Conditions: Anesthesia, General

Treatments: Drug: Desflurane; Drug: Sevoflurane

Study type: Observational

Funder types: Other

Identifiers

NCT01899248

YSJeon_liver transplantation

Details and patient eligibility

About

The purpose of this study is to assess the effects of inhalation agent on corrected QT interval duration during liver transplantation.

Enrollment: 52 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• elective liver transplantation

Exclusion criteria

• age < 18, age > 65
• patient refusal
• re-transplantation

Trial design

52 participants in 2 patient groups

Sevoflurane

Description:

Performing liver transplantation under general anesthesia using sevoflurane

Treatment:

Drug: Sevoflurane

Desflurane

Description:

Performing liver transplantation under general anesthesia using desflurane

Treatment:

Drug: Desflurane